In Vitro Activity of Alpha-Interferon on Granulocyte-Macrophage Precursors in Chronic Myeloid Leukemia (CML): Correlation with Clinical Responsiveness
- 1 January 1992
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 6 (2) , 155-160
- https://doi.org/10.3109/10428199209064889
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodiesBritish Journal of Haematology, 1989
- Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationBlood, 1988
- Sensitivity of Ph1+ CFU-GM to human recombinant interferon ? and ? alone and in combinationAnnals of Hematology, 1988
- Clinical investigation of human alpha interferon in chronic myelogenous leukemiaBlood, 1987
- Differential human interferon alpha receptor expression on proliferating and non-proliferating cellsEuropean Journal of Biochemistry, 1986
- Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferonBritish Journal of Haematology, 1985
- The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cellsBlood, 1985
- Prognostic discrimination in "good-risk" chronic granulocytic leukemiaBlood, 1984
- Human leukocyte interferon preparation blocks granulopoietic differentiationBlood, 1979
- Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord bloodBlood, 1978